Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02939651
Title A Study of Pembrolizumab in Patients With Neuroendocrine Tumors
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Namrata Vijayvergia
Indications

neuroendocrine tumor

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.